Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Avanzanite forms a Pan-European partnership with Agios to introduce PYRUKYND® for rare blood disorders

the European Economic Area, the UK and Switzerland. “This partnership marks a major milestone in our mission to transform how rare disease therapies reach patients in Europe,” said Adam Plich, Founder and CEO of Avanzanite. “We provide biotech...

Lubrizol reveals a significant milestone for its innovative, patented Apisolex™ polymer excipient

Lubrizol announces that an Apisolex™ polymer excipient-enabled drug formulation is in Phase 1 clinical trials. Introduced to the market in 2022, Apisolex polymer excipient is a polyamino acid-based polymer that enhances the solubility of BCS Class...

CollPlant expands its partnership with Stemcell Technologies.

instruments, accessory products, educational resources, and contract assay services that are used by scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research globally. About CollPlant CollPlant is a...

Emulate introduces the AVA™ Emulation System, a groundbreaking high-throughput organ-chip platform designed to accelerate drug development

while cutting consumable costs four-fold and in-lab labor by half compared to current generation technologies. These transformative capabilities give the pharmaceutical industry the practical means to pivot beyond animal testing and into truly...

A New Production Line Dedicated to Sterile Hyaluronic Acid Has Been Inaugurated by HTL Biotechnology

and ensures optimum pharmaceutical quality. This innovation marks a decisive step in the development of new combined formulations, bringing improved clinical benefits for patients in many fields, such as ophthalmology and drug delivery. This €12...

Elysium Therapeutics to Discuss Fentanyl Rebound and Synthetic Opioid Rescue Drug

overdose from synthetic opioids, including oral fentanyl. SOOPR utilizes a proprietary long-acting naloxone reversal formulation with faster onset kinetics versus Narcan® delivered via long-acting injection (LAI) technology. The technology is...

CollPlant Biotechnologies Announces First Quarter 2025 Financial Results and Issues Corporate Update

dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market. For more information please visit http://www.collplant.com.

Samsung Bioepis and Organon’s HADLIMA™ Gains FDA Interchangeability Designation, Expanding Access to Adalimumab Alternative

in children and adolescent patients treated with TNF blockers including adalimumab products. See additional safety information below. The interchangeability designation was based on clinical data from a randomized, double-blind, 1:1 ratio,...

Avenacy Enters U.S. Market with Launch of Doxycycline for Injection, USP

facilitate safe and efficient patient care, Avenacy strives to be a trusted partner for essential medications. For more information, please visit http://www.avenacy.com/.

Eden Expands Access to Glutathione Injection Protocols via Independent Licensed Providers and Pharmacies

Eden, the leading health platform connecting individuals with licensed providers and pharmacies focused on metabolic health, today announced expanded access to a pharmacy-grade compounded glutathione injection protocol. The therapy is now...

Fresenius Kabi Introduces Epinephrine Injection, USP, in 30 mg/30 mL Multi-Dose Vials

are drugs listed on the FDA’s Essential Medicines List. To learn more, visit our More in America page. IMPORTANT SAFETY INFORMATION: Do not inject into buttocks, digits, hands, or feet. Avoid extravasation into tissues, which can cause local...

Otulfi® (ustekinumab-aauz) by Fresenius Kabi Now FDA-Approved as an Interchangeable Biosimilar

Fresenius Kabi, an operating company of Fresenius, and Formycon AG, announced that the U.S. Food and Drug Administration (FDA) designated Otulfi® (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara® (ustekinumab)....

Osteo Bi-Flex® Adds Plant-Based Omega-3s to Promote Whole Body Health and Wellness

joint care supplement brand1 introduced its new Osteo Bi-Flex® Advanced Omega-3 Joint Complex supplement. This new formula helps support joint and whole body health by combining 100 mg of Joint Shield 5-LOXIN Advanced®, a highly concentrated herbal...

Research from Noster finds that a gut bacteria-derived molecule can shrink fat cells and improve metabolism

science into real-world solutions for chronic diseases such as obesity, diabetes, and inflammatory conditions. For more information please visit, https://www.noster.inc/jp/

Eligo Bioscience Receives $5 Million to Accelerate Development of Its Breakthrough Immuno-Dermatology Gene Therapy Platform

from the French government to accelerate the advancement and scaling up of Eligo's proprietary topical gene delivery platform, designed to enable local production of therapeutic biologics directly by skin-resident bacteria. This grant follows...

Kimera® Labs named a semifinalist in the $101 million XPRIZE Healthspan competition for pioneering innovations in healthy aging

top 40 teams selected from over 660 registered applicants across 58 countries—an elite group of innovators working to transform the future of aging and healthcare. Founded in 2012, Kimera Labs is internationally recognized for its groundbreaking...

Rein Therapeutics announces the initiation of the RENEW Phase 2 trial of LTI-03 in patients with IPF

LTI-01 has received Orphan Drug Designation in the U.S. and E.U. and Fast Track Designation in the U.S. For more information, please visit www.reintx.com

Viralgen Partners with Trogenix to Advance AAV Gene Therapy for Glioblastoma

toward first-in-human (FIH) clinical trials for glioblastoma, one of the most aggressive and treatment-resistant forms of brain cancer. Beyond manufacturing, Viralgen has developed a gene-specific titration method and a custom specific formulation...

Niagen Bioscience announces that pharmaceutical-grade Niagen® IV is now available in nearly 600 clinics nationwide.

of Niagen Bioscience, stated, “At the heart of the Niagen Plus ecosystem are our sterile pharmaceutical-grade Niagen NR formulations for IV as well as intramuscular (IM) and subcutaneous (SubQ) injections. These Niagen NR products are high-quality...

INBRAIN Neuroelectronics has been awarded a €4 million grant from Spain’s PERTE Chip Program to advance graphene-based brain-computer interfaces

brain activity for therapeutic purposes. The PERTE Chip initiative - “Strategic Project for Economic Recovery and Transformation of Microelectronics and Semiconductors” - aims to strengthen the design and production capabilities of the...